Liminatus Pharma, Inc. Class A Common Stock
$0.1255
USD
Last updated on --.
24h volume2.22M
24h highest0.14060 USD
24h lowest0.12200 USD
24h Price movement-7.72%
LIMN recent prices
24 Hours
-7.72%-$0.0105
30 days
-24.70%-$0.0457
60 days
-22.61%-$0.0407
90 days
-40.69%-$0.0948
Key data
Previous close0.13600 USD
Market cap8.08M USD
Volume2.22M
P/E ratio--
Dividend yield (TTM)--
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)--
Net income (FY)--
Revenue (FY)--
Last report date--
About Liminatus Pharma, Inc. Class A Common Stock
HeadquartersCERRITOS
Employees (FY)1.00
Listed onNasdaq
LIMN conversion tables
 |  |
|---|---|
| 0.5 LIMN | 0.06275 USD |
| 1 LIMN | 0.1255 USD |
| 5 LIMN | 0.6275 USD |
| 10 LIMN | 1.255 USD |
| |
|---|---|
| 0.5 USD | 3.984 LIMN |
| 1 USD | 7.968 LIMN |
| 5 USD | 39.84 LIMN |
| 10 USD | 79.68 LIMN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LIMN is trading at $0.1255, -7.72% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LIMN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LIMN is currently trading at $0.1255, -7.72% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LIMN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LIMN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LIMN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LIMN's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Liminatus Pharma, Inc. Class A Common Stock's market cap is currently 8.08M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.22M
24h highest0.14060 USD
24h lowest0.12200 USD
24h Price movement-7.72%
Start trade with LIMN Perpetual
Sign up to trade